World Vaccine Congress Europe 2026 has ended. This guide stays up as the record of who was there. Next: WVC Europe 2027, Oct 25–27, 2027 in Lyon
Sanofi at World Vaccine Congress Europe 2026
Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website
Sanofi takes part in 8 sessions at World Vaccine Congress Europe 2026 in Amsterdam. Its sessions cover mRNA vaccine platforms, pandemic preparedness and ways to design and run vaccine trials faster. Specific topics include an H5 pandemic flu mRNA program, vaccine safety monitoring in the AI era and a vaccine designed to treat acne.
| Organization | World Vaccine Congress Europe 2026 Attendance |
|---|---|
Sanofi Paris, France | |
Global pharmaceutical company with a large vaccines business spanning influenza, pediatric, meningitis and mRNA programs. | Talk Mon Oct 19 11:30 Talk Mon Oct 19 14:45 Talk Mon Oct 19 15:30 Talk Tue Oct 20 09:00 The Technology Revolution: Agility for the Wave of Next Generation Vaccines Which newer vaccine platforms, such as RNA, could shorten outbreak response times and extend vaccines to cancer and autoimmune disease. Platforms & delivery Talk Wed Oct 21 12:45 Panel: From Bottleneck to Breakthrough: Reengineering Vaccine Clinical Development Why vaccine development has slowed back to pre-pandemic speeds and which changes, including AI, could make clinical trials faster. Talk Wed Oct 21 13:30 Talk Wed Oct 21 15:00 Panel: Designing Better Vaccine Trials: The Role and Reality of Modelling Whether models built from manufacturing and early trial data can shrink vaccine trials, and what evidence regulators need to trust them. |
Find decision makers at Sanofi
Tell us what you sell and we’ll find the people at Sanofi most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction